Back to Results
First PageMeta Content
Pneumonia / Macrolide antibiotics / Gram-negative bacteria / Polysaccharide encapsulated bacteria / Pathogenic bacteria / Azithromycin / Otitis media / Community-acquired pneumonia / Acute exacerbations of chronic bronchitis / Bacteria / Microbiology / Medicine


FDA Briefing Package: Zithromax (Azithromycin) Oral Suspension Single-Dose and Three-Day Treatment of Acute Otitis Media  Anti-Infective Drugs Advisory Committee
Add to Reading List

Document Date: 2001-11-06 08:14:44

Open Document

File Size: 61,76 KB

Share Result on Facebook

Company

Pfizer Inc. / Abbreviations AE / Respiratory Tract Infections / /

Country

United States / Costa Rica / Canada / /

Currency

USD / /

Event

FDA Phase / /

IndustryTerm

target site / acute otitis media / treatment of a number of infectious diseases / /

MedicalCondition

pharyngitis/tonsillitis / pneumonia / skin structure infections / bacterial infections / skin infections / Community-Acquired Respiratory Tract Infections / infectious diseases / Acute Otitis Media / chronic bronchitis / /

MedicalTreatment

antibiotics / /

Organization

FDA / Anti-Infective Drugs Advisory Committee / /

Product

clarithromycin / erythromycin / penicillin / Azithromycin / Augmentin / Amoxicillin / Zithromax / Ceftriaxone / United States / /

Technology

pharmacokinetics / 48 Per Protocol / /

SocialTag